Design of the foresiGHt Trial: A Multicenter, Randomized, Placebo- and Active-Controlled Trial to Compare Once-Weekly Lonapegsomatropin to Placebo and Daily Somatropin in Adults with Growth Hormone Deficiency (GHD)
Aleksandra Gilis‐Januszewska, Michael Beckert, Charlotte Höybye(Karolinska University Hospital), Yuen Kevin CJ, Allison Komirenko, Aimee D Shu(Ascendis Pharma (Denmark)), Maria Fleseriu(Oregon Health & Science University), Jennifer Kang(Duke University), Meng Mao(Guiyang Medical University), Jorgensen Jens Otto, Wenjie Song(Xijing Hospital)
Cited by 0
Related Papers
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|921
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Burosumab Therapy in Children with X-Linked Hypophosphatemia
|New England Journal of Medicine|2018|479
Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 Years
|Neuroscience Bulletin|2020|468
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
|The Journal of Clinical Endocrinology & Metabolism|2014|394